Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
6.07
-2.46 (-28.84%)
Jun 1, 2026, 1:31 PM EDT - Market open

Co-Diagnostics Revenue

Co-Diagnostics had revenue of $145.95K in the quarter ending March 31, 2026, with 190.30% growth. This brings the company's revenue in the last twelve months to $718.17K, down -79.47% year-over-year. In the year 2025, Co-Diagnostics had annual revenue of $622.49K, down -84.10%.

Revenue (ttm)
$718.17K
Revenue Growth
-79.47%
P/S Ratio
43.44
Revenue / Employee
$6,245
Employees
115
Market Cap
22.20M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025622.49K-3.29M-84.10%
Dec 31, 20243.92M-2.90M-42.53%
Dec 31, 20236.81M-27.41M-80.09%
Dec 31, 202234.22M-63.67M-65.04%
Dec 31, 202197.89M23.33M31.30%
Dec 31, 202074.55M74.34M34,579.91%
Dec 31, 2019214.97K175.06K438.63%
Dec 31, 201839.91K32.25K420.90%
Dec 31, 20177.66K--
Dec 31, 2016---
Dec 31, 201510.00K--
Dec 31, 2014---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray428.57M
Nortech Systems121.79M
TELA Bio80.81M
Myomo41.21M
Cytosorbents37.20M
Lifeward20.92M
NeuroOne Medical Technologies12.72M
Pulsenmore12.55M
Revenue Rankings